Glycan-binding profile of DC-like cells

Area of Science:

• Immunology
• Vaccinology
• Cell Biology

Background:

• Dendritic cells (DCs) are crucial for vaccine efficacy through glycan-mediated targeting.
• Identifying specific glycan-vector interactions requires understanding DC glycan-binding profiles.
• Challenges exist in profiling circulating DCs due to low cell numbers.

Purpose of the Study:

• To evaluate THP-1 and DC2.4 cell lines as models for human dendritic cells (DCs) in glycan binding.
• To assess the glycan-binding profiles of these cell lines and murine DC subpopulations.
• To determine the suitability of murine models for predicting human DC interactions.

Main Methods:

• Probing THP-1 and DC2.4 cell lines with known human DC-binding glycans.
• Testing glycan binding on murine CD14low/-CD80+CD11c+CD16+ cells.
• Comparing glycan binding of cell lines and primary cells.

Main Results:

• Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ bound to both cell lines and murine cells.
• Primary human DCs bound GalNAcα1-3Galβ (A_di), a potent ligand, which cell lines did not.
• Murine DC glycan profiles showed limitations, especially in BALB/c strain.

Conclusions:

• THP-1 and DC2.4 cell lines are not adequate models for studying DC lectin binding.
• Murine DC glycan profiles may offer insights but miss crucial interactions for human DC targeting.
• Results from murine studies require careful interpretation for human vaccine development.